Saakshi Medtech seeks waiver for Q4FY26 filing delay
Saakshi Medtech and Panels Limited has requested the National Stock Exchange of India (NSE) to waive a ₹2,000 fine imposed for a one-day delay in submitting its shareholding pattern for the quarter ended March 31, 2026. The company attributed the delay to an unforeseen technical issue on the NEAPS portal and confirmed the filing was completed on May 22, 2026. The Board of Directors has been apprised of the incident and has directed the strengthening of internal compliance mechanisms.

*this image is generated using AI for illustrative purposes only.
Saakshi Medtech and Panels Limited has approached the National Stock Exchange of India (NSE) to waive a ₹2,000 penalty levied for a one-day delay in filing its shareholding pattern for the quarter ended March 31, 2026. The company attributed the delay to an unforeseen technical issue on the NEAPS portal, which disrupted the upload process despite preparatory steps being taken within the prescribed timelines. The disclosure was eventually submitted on May 22, 2026, prior to the issuance of the penalty notice on May 14, 2026.
The NSE issued the notice under Regulation 31 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, citing non-compliance with the standard operating procedure for filing shareholding patterns. The exchange identified a one-day delay in compliance, resulting in a base fine of ₹2,000 and an additional GST of ₹360, bringing the total payable amount to ₹2,360. The notice warned that failure to pay the fine or ensure compliance could lead to the freezing of promoter shareholdings and a shift in trading to the 'Trade for Trade' basis.
In its response, Saakshi Medtech & Panels stated that the delay was inadvertent and unintentional, occurring despite bona fide efforts to comply with regulatory requirements. The company emphasized that there was no deliberate or malafide intent behind the non-compliance. It further noted that the matter had been placed before its Board of Directors, who have taken cognizance of the delay and directed the strengthening of internal compliance monitoring and reporting mechanisms to prevent recurrence.
The company has formally requested the waiver of the fine, citing the bona fide nature of the delay arising from technical difficulties and the fact that compliance has since been achieved. It assured the exchange of its continued cooperation and commitment to maintaining high standards of regulatory compliance. Mrs. Mayuri Aniket Latkar, CFO and Whole-Time Director, signed the response submitted on June 9, 2026.
Details of Penalty
| Regulation | Quarter | Fine amount per day (₹) | Days of non-compliance | Fine amount (₹) |
|---|---|---|---|---|
| REGULATION 31(1) | 31-Mar-2026 | 2000 | 1 | 2000 |
| Total Fine | 2000 | |||
| GST @18% | 360 | |||
| Total | 2360 |
Historical Stock Returns for Saakshi Medtech & Panels
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.83% | +1.95% | -5.98% | +33.87% | +53.21% | +65.00% |
How will the NSE likely respond to the waiver request given the technical issue justification?
What specific internal compliance measures will the Board implement to prevent future portal-related delays?
Could this incident trigger a broader review of the NEAPS portal's reliability by the exchange?





























